| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), QURE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 540.3K | $10.48M | - | |
| CFO | 226.6K | $2.05M | - | |
| Other | 133.2K | $3.69M | - | |
| Other | 108.9K | $2.95M | - | |
| Other | 50.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Gut Robert65 | Director | Sale+OE | 25,613 | $24.62 | $630,483.17 | -44.2% | -33.2% | - | |
| Jan 9, 2026 | Kaye Jack48 | Director | Sale+OE | 6,390 | $27.28 | $174,319.20 | -23.8% | -35.6% | - | |
| Nov 6, 2025 | Gut Robert65 | Director | Sale+OE | 31,434 | $27.26 | $856,881.00 | -43.9% | -3.1% | - | |
| Nov 4, 2025 | Kaye Jack48 | Director | Sale+OE | 38,810 | $30.34 | $1,177,517.30 | -65.5% | -18.9% | - | |
| Sep 26, 2025 | Klemt Christian58 | Chief Financial Officer | Sale+OE | 18,000 | $52.51 | $945,120.00 | -7.6% | -54.3% | - | |
| Sep 24, 2025 | Kapusta Matthew C64 | CEO, Managing Director | Sale+OE | 226,316 | $41.46 | $9,382,472.66 | -25.8% | -49.1% | - | |
| Jun 27, 2025 | Abi-Saab Walid | Chief Medical Officer | Sell | 1,466 | $13.92 | $20,406.72 | -1.0% | +279.9% | +242.8% | |
| Jun 20, 2025 | Springhorn Jeremy P.46 | Director | Sell | 2,112 | $14.45 | $30,518.40 | -5.3% | +3.7% | +212.4% | |
| Jun 20, 2025 | Post Leonard E | Director | Sell | 2,112 | $14.45 | $30,518.40 | -6.6% | +3.7% | +212.4% | |
| Jun 20, 2025 | Kaye Jack48 | Director | Sell | 2,112 | $14.45 | $30,518.40 | -9.4% | +3.7% | +212.4% |